Menu
Recruiting NCT06490211

The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors

Observational Urinary System Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Urinary System Carcinoma. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intratumoral Microbiome.

Primary outcome measures

  • progression-free survival [Time frame: 2 years]

Eligibility criteria

Inclusion criteria

  • Patients were treated for bladder cancer, kidney cancer, and prostate cancer in Wuhan Union Hospital from January 2024 to January 2026;
  • Aged > 18 years old;
  • Urinalysis, urine exfoliated cells, ultrasound, CT, and MR examinations indicated the above tumors;
  • Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion criteria

  • Poor image quality;
  • Incomplete clinical data or loss of follow-up;
  • Presence of another primary malignant tumor other than urinary tract tumor;
  • Unclear pathological diagnosis

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Union Hospital,Tongji Medical College,Huazhong University of Science and Technology — Wuhan

Identifiers

NCT: NCT06490211 · S189

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗